{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:36:45Z","timestamp":1793191005555,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.bbi.2024.06.003","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T20:29:13Z","timestamp":1717878553000},"page":"327-338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Associations between soluble urokinase plasminogen activator receptor (suPAR) concentration and psychiatric disorders \u2013 A systematic review and meta-analysis"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2480-7656","authenticated-orcid":false,"given":"Jennifer","family":"Murphy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zierotin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mongan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subash R.","family":"Susai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"O\u2019Donoghue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Cotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2024.06.003_b0005","doi-asserted-by":"crossref","first-page":"1027345","DOI":"10.3389\/fgene.2022.1027345","article-title":"The impact of violating the independence assumption in meta-analysis on biomarker discovery","volume":"13","author":"Abbas-Aghababazadeh","year":"2023","journal-title":"Front. Genet."},{"issue":"10","key":"10.1016\/j.bbi.2024.06.003_b0010","first-page":"e30733","article-title":"Relation between diabetes and psychiatric disorders","volume":"14","author":"Akhaury","year":"2022","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.bbi.2024.06.003_b0015","doi-asserted-by":"crossref","first-page":"144","DOI":"10.9758\/cpn.2013.11.3.144","article-title":"Effects of antipsychotics on the inflammatory response system of patients with schizophrenia in peripheral blood mononuclear cell cultures","volume":"11","author":"Al-Amin","year":"2013","journal-title":"Clin. Psychopharmacol. Neurosci.: Off. Sci. J. Korean College Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2024.06.003_b0020","unstructured":"American Psychological Association (APA). (2023). APA PsychoInfo. Available: https:\/\/www.apa.org\/pubs\/databases\/psycinfo."},{"key":"10.1016\/j.bbi.2024.06.003_b0025","doi-asserted-by":"crossref","unstructured":"Arciniegas D. B. (2015). Psychosis.Continuum (Minneapolis, Minn.),21(3 Behavioral Neurology and Neuropsychiatry), 715\u2013736. https:\/\/doi.org\/10.1212\/01.CON.0000466662.89908.e7.","DOI":"10.1212\/01.CON.0000466662.89908.e7"},{"issue":"9","key":"10.1016\/j.bbi.2024.06.003_b0030","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1007\/s00134-012-2613-1","article-title":"Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review","volume":"38","author":"Backes","year":"2012","journal-title":"Intensive Care Med."},{"issue":"3","key":"10.1016\/j.bbi.2024.06.003_b0035","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/0004867417714336","article-title":"Randomised controlled trial of a healthy lifestyle intervention among smokers with psychotic disorders: Outcomes to 36 months","volume":"52","author":"Baker","year":"2018","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.bbi.2024.06.003_b0040","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.schres.2020.11.051","article-title":"Elevated levels of soluble urokinase plasminogen activator receptor as a low-grade inflammation marker in schizophrenia: A case-control study","volume":"228","author":"Bigseth","year":"2021","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2024.06.003_b0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbi.2021.06.018","article-title":"Linking stressful life events and chronic inflammation using suPAR (soluble urokinase plasminogen activator receptor)","volume":"97","author":"Bourassa","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2024.06.003_b0050","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41398-022-02142-2","article-title":"Transdiagnostic inflammatory subgroups among psychiatric disorders and their relevance to role functioning: a nested case-control study of the ALSPAC cohort","volume":"12","author":"Byrne","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2024.06.003_b0055","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.clinbiochem.2019.05.010","article-title":"Analytical, biochemical and clearance considerations of soluble urokinase plasminogen activator receptor (suPAR) in healthy individuals","volume":"69","author":"Chew-Harris","year":"2019","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.bbi.2024.06.003_b0060","unstructured":"Clarivate. (2023). Web of science. Available: https:\/\/access.clarivate.com\/login?app=wos&alternative=true&shibShireURL=https:%2F%2Fwww.webofknowledge.com%2F%3Fauth%3DShibboleth&shibReturnURL=https:%2F%2Fwww.webofknowledge.com%2F%3Fmode%3DNextgen%26action%3Dtransfer%26path%3D%252Fwos%26DestApp%3DUA&referrer=mode%3DNextgen%26path%3D%252Fwos%26DestApp%3DUA%26action%3Dtransfer&roaming=true."},{"key":"10.1016\/j.bbi.2024.06.003_b0065","doi-asserted-by":"crossref","unstructured":"Costello, H., Gould, R. L., Abrol, E., & Howard, R. (2019). Systematic review and meta-analysis of the association between peripheral inflammatory cytokines and generalised anxiety disorder.BMJ open,9(7), e027925. https:\/\/doi.org\/t0.1136\/bmjopen-2018-027925.","DOI":"10.1136\/bmjopen-2018-027925"},{"issue":"1","key":"10.1016\/j.bbi.2024.06.003_b0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/acps.13416","article-title":"Inflammation in first-episode psychosis: The contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta-analysis","volume":"146","author":"Dunleavy","year":"2022","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.bbi.2024.06.003_b0075","unstructured":"Elsevier. (2023a). Embase. Available: ."},{"key":"10.1016\/j.bbi.2024.06.003_b0080","unstructured":"Embase. (2023b). Scopus. Available: https:\/\/www.scopus.com\/home.uri?zone=header&origin=."},{"issue":"3","key":"10.1016\/j.bbi.2024.06.003_b0085","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2796.2010.02252.x","article-title":"Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population","volume":"268","author":"Eugen-Olsen","year":"2010","journal-title":"J. Intern. Med."},{"issue":"2","key":"10.1016\/j.bbi.2024.06.003_b0090","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.psychres.2015.10.001","article-title":"A lifestyle intervention for primary care patients with depression and anxiety: A randomised controlled trial","volume":"230","author":"Forsyth","year":"2015","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.bbi.2024.06.003_b0095","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/schbul\/sby125","article-title":"Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis","volume":"45","author":"Fraguas","year":"2019","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2024.06.003_b0100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.psychres.2016.01.018","article-title":"Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia","volume":"236","author":"Genc","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2024.06.003_b0110","doi-asserted-by":"crossref","unstructured":"Giocondo, J. G., Salum, G, A., Gadelha, A., Argolo, F, C., Simioni, R, A., Mari, J, J., Miguel, E, C., Bressan, R, A., Rohde, L, A., Pan, P, M. (2021). Psychotic-like Experiences and Common Mental Disorders in Childhood and Adolescence: Bidirectional and Trans-diagnostic Associations in a Longitudinal Community-based Study,Schizophrenia Bulletin Open, 2(1)https:\/\/doi.org\/10.1093\/schizbullopen\/sgab028.","DOI":"10.1093\/schizbullopen\/sgab028"},{"issue":"12","key":"10.1016\/j.bbi.2024.06.003_b0115","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2024.06.003_b0120","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1186\/1471-2458-11-878","article-title":"Association between infection early in life and mental disorders among youth in the community: a cross-sectional study","volume":"11","author":"Goodwin","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.bbi.2024.06.003_b0125","doi-asserted-by":"crossref","DOI":"10.1177\/1177271917704193","article-title":"Effects of Acute Exercise on Circulating Soluble Form of the Urokinase Receptor in Patients With Major Depressive Disorder","volume":"12","author":"Gustafsson","year":"2017","journal-title":"Biomark. Insights"},{"issue":"10","key":"10.1016\/j.bbi.2024.06.003_b0130","doi-asserted-by":"crossref","first-page":"e110555","DOI":"10.1371\/journal.pone.0110555","article-title":"Soluble urokinase plasminogen activator receptor as a marker for use of antidepressants","volume":"9","author":"Haastrup","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2024.06.003_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12979-018-0141-8","article-title":"Healthy lifestyles reduce suPAR and mortality in a Danish general population study","volume":"16","author":"Haupt","year":"2019","journal-title":"Immunity & Ageing : I & A"},{"key":"10.1016\/j.bbi.2024.06.003_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbih.2023.100685","article-title":"SuPAR in major depression: Association with 26 weeks antidepressant response and 10-year depression outcomes","volume":"33","author":"Haupt","year":"2023","journal-title":"Brain, Behavior, & Immunity - Health"},{"key":"10.1016\/j.bbi.2024.06.003_b0145","doi-asserted-by":"crossref","unstructured":"Hedges, L. V., Tipton, E., & Johnson, M. C. (2010). Robust variance estimation in meta-regression with dependent effect size estimates. Research Synthesis Methods, 1, 39\u201365. https:\/\/doi.org\/10. 1002\/jrsm.5.","DOI":"10.1002\/jrsm.5"},{"issue":"7","key":"10.1016\/j.bbi.2024.06.003_b0150","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00125-013-2914-0","volume":"56","author":"Heraclides","year":"2013","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.bbi.2024.06.003_b0155","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a metaanalysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"issue":"10","key":"10.1016\/j.bbi.2024.06.003_b0160","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cjca.2015.03.023","article-title":"suPAR: A New Biomarker for Cardiovascular Disease?","volume":"31","author":"Hodges","year":"2015","journal-title":"Can. J. Cardiol."},{"issue":"1","key":"10.1016\/j.bbi.2024.06.003_b0165","doi-asserted-by":"crossref","first-page":"10","DOI":"10.9758\/cpn.2020.18.1.10","article-title":"Anti-inflammatory Strategies for Schizophrenia: A Review of Evidence for Therapeutic Applications and Drug Repurposing","volume":"18","author":"Hong","year":"2020","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"3","key":"10.1016\/j.bbi.2024.06.003_b0170","doi-asserted-by":"crossref","DOI":"10.1177\/22799036221106613","article-title":"Childhood adversities and mental health problems: A systematic review","volume":"11","author":"Juwariah","year":"2022","journal-title":"J. Public Health Res."},{"key":"10.1016\/j.bbi.2024.06.003_b0175","first-page":"161","article-title":"Childhood infection and adult schizophrenia: A meta-analysis of population-based studies","volume":"139","author":"Khandaker","year":"2012","journal-title":"Schizophr. Bull."},{"issue":"10","key":"10.1016\/j.bbi.2024.06.003_b0180","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/jamapsychiatry.2014.1332","article-title":"Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study","volume":"71","author":"Khandaker","year":"2014","journal-title":"JAMA Psychiat."},{"issue":"12","key":"10.1016\/j.bbi.2024.06.003_b0185","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","article-title":"Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials","volume":"71","author":"K\u00f6hler","year":"2014","journal-title":"JAMA Psychiat."},{"issue":"2","key":"10.1016\/j.bbi.2024.06.003_b0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/acps.12671","article-title":"Infections and exposure to anti-infective agents and the risk of severe mental disorders: a nationwide study","volume":"135","author":"K\u00f6hler","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.bbi.2024.06.003_b0195","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4088\/JCP.09m05117yel","article-title":"Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double blind, placebo-controlled trial","volume":"71","author":"Laan","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2024.06.003_b0200","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbi.2021.12.027","article-title":"Longitudinal associations between adolescent\u2019s individualised risk for depression and inflammation in a UK cohort study","volume":"101","author":"Latham","year":"2022","journal-title":"BrainBehaviour, and Immunity"},{"key":"10.1016\/j.bbi.2024.06.003_b0205","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jad.2011.08.003","article-title":"Interleukin (IL)-6, tumour necrosis factor alpha (TNF-\u03b1) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression","volume":"139","author":"Liu","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2024.06.003_b0210","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bbi.2021.08.227","article-title":"Inflammatory burden in adolescents with prolonged parent-child separation","volume":"98","author":"Liu","year":"2021","journal-title":"Brain, Behaviour, and Immunity"},{"key":"10.1016\/j.bbi.2024.06.003_b0215","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbi.2021.08.224","article-title":"suPAR: A newer biomarker of systemic chronic inflammation","volume":"98","author":"Marsland","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"9","key":"10.1016\/j.bbi.2024.06.003_b0220","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","article-title":"Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression","volume":"65","author":"Miller","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.06.003_b0225","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/npp.2016.167","article-title":"Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation","volume":"42","author":"Miller","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2024.06.003_b0230","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/eip.12859","article-title":"Role of inflammation in the pathogenesis of schizophrenia: A review of the evidence, proposed mechanisms and implications for treatment","volume":"14","author":"Mongan","year":"2020","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.bbi.2024.06.003_b0235","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbi.2023.03.025","article-title":"Associations between plasma inflammatory markers and psychotic disorder, depressive disorder and generalised anxiety disorder in early adulthood: A nested case-control study","volume":"111","author":"Mongan","year":"2023","journal-title":"BrainBehavior, and Immunity"},{"issue":"4","key":"10.1016\/j.bbi.2024.06.003_b0240","article-title":"The relationship between depression and risk of metabolic syndrome: a meta-analysis of observational studies","volume":"7","author":"Moradi","year":"2021","journal-title":"Clinical Diabetes and Endocrinology"},{"key":"10.1016\/j.bbi.2024.06.003_b0245","unstructured":"National Library of Medicine. (2023). PubMed. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/advanced\/."},{"issue":"2","key":"10.1016\/j.bbi.2024.06.003_b0250","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41569-020-00463-7","article-title":"Cardiovascular disease in patients with severe mental illness","volume":"18","author":"Nielsen","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.bbi.2024.06.003_b0255","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/schbul\/sbu118","article-title":"Soluble urokinase-type plasminogen activator receptor levels in patients with schizophrenia","volume":"41","author":"Nielsen","year":"2015","journal-title":"Schizophr. Bull."},{"issue":"135","key":"10.1016\/j.bbi.2024.06.003_b0260","article-title":"Cardiovascular Effects and Benefits of Exercise","volume":"5","author":"Nystoriak","year":"2018","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"12","key":"10.1016\/j.bbi.2024.06.003_b0265","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1017\/S0033291719001454","article-title":"Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels","volume":"49","author":"Osimo","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2024.06.003_b0270","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.psyneuen.2018.02.009","article-title":"Decreased circulating urokinase plasminogen activator receptor (uPAR) concentration in acute episodes of bipolar disorder; could it be a reflection of axonal injury","volume":"90","author":"Ozpercin","year":"2018","journal-title":"Psycho-Neuroendocrinology"},{"key":"10.1016\/j.bbi.2024.06.003_b0275","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (clinical Research Ed.)"},{"key":"10.1016\/j.bbi.2024.06.003_b0280","series-title":"Meta-Analysis in Stata: An Updated Collection from the Stata Journal","author":"Palmer","year":"2016"},{"key":"10.1016\/j.bbi.2024.06.003_b0285","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.plefa.2016.05.007","article-title":"People with schizophrenia and depression have a low omega-3 index","volume":"110","author":"Parletta","year":"2016","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.bbi.2024.06.003_b0290","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jpsychires.2023.01.042","article-title":"Anti-inflammatory effects of 2nd generation antipsychotics in patients with schizophrenia: A systematic review and meta-analysis","volume":"160","author":"Patlola","year":"2023","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.bbi.2024.06.003_b0295","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11121-021-01246-3","article-title":"Meta-analysis with Robust Variance Estimation: Expanding the Range of Working Models","volume":"23","author":"Pustejovsky","year":"2022","journal-title":"Prevent. Sci.: Off. J. Soc. Prevent. Res."},{"issue":"1","key":"10.1016\/j.bbi.2024.06.003_b0300","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jamapediatrics.2019.3875","article-title":"Association of Adverse Experiences and Exposure to Violence in Childhood and Adolescence With Inflammatory Burden in Young People","volume":"174","author":"Rasmussen","year":"2020","journal-title":"JAMA Paediatrics"},{"issue":"2","key":"10.1016\/j.bbi.2024.06.003_b0305","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/gerona\/glaa178","article-title":"Association Between Elevated suPAR, a New Biomarker of Inflammation, and Accelerated Aging","volume":"76","author":"Rasmussen","year":"2021","journal-title":"J. Gerontol.: Med. Sci."},{"key":"10.1016\/j.bbi.2024.06.003_b0310","doi-asserted-by":"crossref","unstructured":"Rasmussen, L, J, H., Petersen, J. E. V., & Eugen-Olsen, J. (2021a). Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation. Frontiers in Immunology, 12, 780641. doi: 10.3389\/fimmu.2021.780641.","DOI":"10.3389\/fimmu.2021.780641"},{"issue":"13","key":"10.1016\/j.bbi.2024.06.003_b0315","article-title":"Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models","volume":"6","author":"Samsom","year":"2015","journal-title":"Front. Psych."},{"issue":"11","key":"10.1016\/j.bbi.2024.06.003_b0320","first-page":"1","article-title":"Scoping reviews, systematic reviews, and meta-analysis: Applications in veterinary medicine","volume":"7","author":"Sargeant","year":"2020","journal-title":"Frontiers in Veterinary Science"},{"issue":"10","key":"10.1016\/j.bbi.2024.06.003_b0325","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.scib.2021.01.032","article-title":"Schizophrenia: a classic battle ground of nature versus nurture debate","volume":"66","author":"St Clair","year":"2021","journal-title":"Science Bulletin"},{"issue":"10","key":"10.1016\/j.bbi.2024.06.003_b0330","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1176\/appi.ajp.157.10.1552","article-title":"Genetic epidemiology of major depression: review and meta-analysis","volume":"157","author":"Sullivan","year":"2000","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.bbi.2024.06.003_b0335","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbi.2021.08.209","article-title":"Associations between childhood victimization, inflammatory biomarkers and psychotic phenomena in adolescence: A longitudinal cohort study","volume":"98","author":"Trotta","year":"2021","journal-title":"Brain, Behaviour, and Immunity"},{"issue":"1\u20133","key":"10.1016\/j.bbi.2024.06.003_b0340","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2014.03.005","article-title":"Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis","volume":"155","author":"Upthegrove","year":"2014","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.bbi.2024.06.003_b0345","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jad.2013.06.004","article-title":"CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies","volume":"150","author":"Valkanova","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bbi.2024.06.003_b0350","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40620-022-01344-7","article-title":"Assay-related differences in SuPAR levels: implications for measurement and data interpretation","volume":"36","author":"Vasbinder","year":"2023","journal-title":"J. Nephrol."},{"issue":"10","key":"10.1016\/j.bbi.2024.06.003_b0355","doi-asserted-by":"crossref","first-page":"e0140052","DOI":"10.1371\/journal.pone.0140052","article-title":"Increased Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in Plasma of Suicide Attempters","volume":"10","author":"Ventorp","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2024.06.003_b0360","article-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2021","journal-title":"The Ottawa Hospital."},{"issue":"2","key":"10.1016\/j.bbi.2024.06.003_b0365","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/2013.jamapsychiatry.102","article-title":"Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals","volume":"70","author":"Wium-Andersen","year":"2013","journal-title":"JAMA Psychiat."},{"issue":"1","key":"10.1016\/j.bbi.2024.06.003_b0370","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41398-019-0570-y","article-title":"Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses","volume":"9","author":"Yuan","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2024.06.003_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2023.110740","article-title":"Peripheral cytokine levels across psychiatric disorders: A systematic review and network meta-analysis","volume":"125","author":"Zhang","year":"2023","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124004446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124004446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T15:09:34Z","timestamp":1721660974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159124004446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":74,"alternative-id":["S0889159124004446"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2024.06.003","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between soluble urokinase plasminogen activator receptor (suPAR) concentration and psychiatric disorders \u2013 A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2024.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}